Successful Remission of Refractory Plantar Warts with Cantharidin Plus in an Immunosuppressed Patient

Main Article Content

Afsoon Ghafari-Saravi


plantar warts, verruca plantaris, verruca vulgaris, immunosuppression, human papillomavirus, transplant


Organ transplant patients on immunosuppressive therapies are susceptible to developing refractory human papillomavirus (HPV) infections including cutaneous warts. These warts are known to respond to conservative treatment modalities in the immunocompetent but are often refractory to multiple treatments in the immunosuppressed. Here we report a case of an immunosuppressed adult with plantar warts recalcitrant to numerous therapies that was ultimately treated successfully with cantharidin-podophyllotoxin-salicylic acid (CPS) monotherapy. After 19 treatment sessions over a 16-month time period, complete resolution was achieved. CPS may be a promising treatment modality in cases of severe, refractory verruca plantaris such as those seen in our immunosuppressed patient.


1. Penn I. Post-transplant kidney cancers and skin cancers (including Kaposi’s sarcoma). Cancer in organ transplant recipients. Springer; 1991:46-53.

2. Dyall‐Smith D, Trowell H, Dyall‐Smith ML. Benign human papillomavirus infection in renal transplant recipients. International journal of dermatology. 1991;30(11):785-789.

3. Joly P, Bastuji-Garin S, Frances C, et al. Squamous cell carcinomas are associated with verrucokeratotic cutaneous lesions but not with common warts in organ-transplant patients. A case-control study. Transplantation. 2010;89(10):1224-1230.

4. D’Souza GF, Zins JE. Severe plantar warts in an immunocompromised patient. New England Journal of Medicine. 2017;377(3):267-267.

5. Dobson JS, Harland CC. Pulsed dye laser and intralesional bleomycin for the treatment of recalcitrant cutaneous warts. Lasers in surgery and medicine. 2014;46(2):112-116.

6. Lee AN, Mallory SB. Contact immunotherapy with squaric acid dibutylester for the treatment of recalcitrant warts. Journal of the American Academy of Dermatology. 1999;41(4):595-599.

7. Nofal A, Adel L, Fawzy M, Elkholy BM. Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative. Dermatologic Therapy. 2022:e15440.